EcoDrugPlus

Tyrosinase

Ensembl ID : ENSAMXG00000008748
Gene Symbol: TYR
4 Cross references
197 Possible Orthologues:

Tyrosinase-Like

Ensembl ID : ENSAMXG00000041832
Gene Symbol: LOC103040843
3 Cross references
203 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSAMXG00000016719
Gene Symbol: TH
3 Cross references
188 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSAMXG00000011333
Gene Symbol: TIE1
3 Cross references
207 Possible Orthologues:

Tyrosine-Protein Kinase Lyn-Like

Ensembl ID : ENSAMXG00000014106
Gene Symbol: LOC103026730
3 Cross references
196 Possible Orthologues:

Tyrosine-Protein Kinase Fyna

Ensembl ID : ENSAMXG00000020869
Gene Symbol: LOC103043249
3 Cross references
192 Possible Orthologues:

Tyrosine-Protein Kinase Yes

Ensembl ID : ENSAMXG00000013306
Gene Symbol: LOC103029125
3 Cross references
195 Possible Orthologues:

Uncharacterized Loc103032641

Ensembl ID : ENSAMXG00000041936
Gene Symbol: LOC103032641
2 Cross references
194 Possible Orthologues:

Utrophin

Ensembl ID : ENSAMXG00000000945
Gene Symbol: UTRN
1 Cross references
253 Possible Orthologues:

Vascular Endothelial Growth Factor A-A-Like

Ensembl ID : ENSAMXG00000009508
Gene Symbol: LOC103035447
3 Cross references
180 Possible Orthologues:

Vascular Endothelial Growth Factor Ab

Ensembl ID : ENSAMXG00000039448
Gene Symbol: VEGFAB
1 Cross references
200 Possible Orthologues:

Vasopressin V2 Receptor-Like

Ensembl ID : ENSAMXG00000017936
Gene Symbol: LOC103045451
2 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).